The co-treatment of A549 cells with Cur and carboplatin revealed the suppression of the AKT-IKKα axis and downstream NF-κB and the inhibition of ERK1/2 activation, ultimately contributing to reduced cancer cell growth and elevated apoptosis [84]. The gene discussed is AKT1; the disease is cancer.